MSE
REGN icon

MUFG Securities EMEA’s Regeneron Pharmaceuticals REGN Stock Holding History

MUFG Securities EMEA’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,000
Closed -$256K – 211
2017
Q4 		$256K Hold
4,000
– – 0.01% 139
2017
Q3 		$1.79M Hold
4,000
– – 0.06% 84
2017
Q2 		$1.97M Buy
+4,000
New +$1.75M 0.07% 58

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MUFG Securities EMEA's REGN Position: Q1 2026 in Review

MUFG Securities EMEA increased its Regeneron Pharmaceuticals (REGN) stake by 315% in Q1 2026, buying an estimated $9.95M and bringing the position to 17,132 shares worth $13.2M. The position accounts for 0.2% of the portfolio, ranked #86.

MUFG Securities EMEA first reported a position in REGN in Q3 2016 and has held it in 28 quarters since. The position peaked at $19.8M in Q4 2017. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • MUFG Securities EMEA held 17,132 shares of Regeneron Pharmaceuticals worth $13.2M as of Q1 2026.
  • MUFG Securities EMEA bought 13,000 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $9.95M.
  • Regeneron Pharmaceuticals made up 0.2% of MUFG Securities EMEA's portfolio in Q1 2026, its #86 holding.
  • MUFG Securities EMEA first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 28 quarters since.
  • MUFG Securities EMEA's Regeneron Pharmaceuticals position peaked at $19.8M in Q4 2017.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.